Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating substantial results in the treatment of type 2 diabetes. This artificial peptide resembles the actions of naturally present GLP-1, a https://socialmphl.com/story23032883/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes